Division of Acute Care Surgery, Department of Surgery, Loma Linda University Medical Center, Loma Linda, CA, USA.
Outcomes Research Laboratories (CORELAB), David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
Am Surg. 2024 Apr;90(4):754-761. doi: 10.1177/00031348231211041. Epub 2023 Oct 30.
With reported improvements in patient outcomes, surgical stabilization of rib fractures (SSRF) has been increasingly adopted. While institutional series have sought to define the role of early SSRF, large scale analysis remains lacking. The present study evaluated clinical and financial outcomes of SSRF in a nationally representative cohort.
Patients (≥16 years) admitted with multiple rib fractures were identified using the 2016-2020 National Inpatient Sample. Those who underwent rib plating >14 days following admission were omitted. Using restricted cubic spline analysis, patients who underwent SSRF within 2 days of hospitalization were classified as while fixation >2 days were deemed Multivariable regressions were used to evaluate the association of operative timing on outcomes of interest.
Of 8150 patients meeting final inclusion criteria, 4090 (50.2%) were . Compared to tended to be older but were of comparable race, primary payer, and income quartile. Traumatic mechanism was also similar but rates of concomitant sternal fracture as well as intra-abdominal and cardiac injuries were higher in . After adjustment, was associated with lower odds of respiratory complications, which included need for mechanical ventilation, prolonged mechanical ventilation, and pneumonia, compared to was associated with similar hospitalization duration but had lower incremental costs (β: -$19.1 K, 95% CI: -24.1 to -14.2).
Early SSRF was associated with lower likelihood of a number of respiratory complications and in-hospital costs. While patient selection criteria may limit our findings, expeditious fixation may limit morbidity while enhancing value of care.
随着患者预后的改善,肋骨骨折的手术固定(SSRF)已被越来越多地采用。虽然机构系列研究试图确定早期 SSRF 的作用,但仍缺乏大规模的分析。本研究评估了全国代表性队列中 SSRF 的临床和财务结果。
使用 2016 年至 2020 年国家住院患者样本,确定了因多发性肋骨骨折入院的患者。排除了在入院后 14 天以上进行肋骨板固定的患者。通过限制立方样条分析,将在入院后 2 天内接受 SSRF 的患者分类为 ,而将固定时间>2 天的患者视为 。多变量回归用于评估手术时机与感兴趣结局的关联。
在符合最终纳入标准的 8150 名患者中,4090 名(50.2%)为 。与 相比, 患者年龄较大,但种族、主要支付方和收入四分位数相似。创伤机制也相似,但并发胸骨骨折以及腹部和心脏损伤的发生率在 中更高。调整后,与机械通气、延长机械通气和肺炎等呼吸并发症的低几率相关,与住院时间相似,但增量成本较低(β:-19.1 千美元,95%置信区间:-24.1 至-14.2)。
早期 SSRF 与多种呼吸系统并发症和住院费用的低发生率相关。虽然患者选择标准可能限制了我们的发现,但快速固定可能会降低发病率,同时提高护理的价值。